Citations per year, relative to T Taguchi T Taguchi (= 1×)
peers
Yoshiteru Terashima
Countries citing papers authored by T Taguchi
Since
Specialization
Citations
This map shows the geographic impact of T Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Taguchi more than expected).
This network shows the impact of papers produced by T Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Taguchi. The network helps show where T Taguchi may publish in the future.
Co-authorship network of co-authors of T Taguchi
This figure shows the co-authorship network connecting the top 25 collaborators of T Taguchi.
A scholar is included among the top collaborators of T Taguchi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with T Taguchi. T Taguchi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Narahara, H., Tetsushi Otani, Tetsuo Iwanaga, et al.. (1998). [A cooperative study on concomitant with low-dose divided administration of cisplatin (CDDP) and sustained drip infusion of 5-fluorouracil (5-FU) for unresectable advanced gastric cancer. Osaka Cisplatin Gastric Cancer Study Group].. PubMed. 25(7). 1021–6.1 indexed citations
3.
Sugano, Kenji, Ota K, T Taguchi, et al.. (1995). [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].. PubMed. 22(5). 627–37.3 indexed citations
Yabushita, Kazuhisa, T Taguchi, Junko Ota, et al.. (1995). [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].. PubMed. 22(7). 925–32.1 indexed citations
6.
Taguchi, T, et al.. (1995). [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].. PubMed. 22(7). 903–10.1 indexed citations
7.
K, Ota, T Taguchi, N. Ogawa, et al.. (1995). [A randomized early phase II study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group].. PubMed. 22(4). 521–9.1 indexed citations
8.
Niitani, H, Kiyoyuki Furuse, M. Fukuoka, Kazuya Hasegawa, & T Taguchi. (1994). Phase I clinical study on new vinca alkaloid derivative, KW 2307 (vinorelbine). Gan to kagaku ryōhō. 21(2). 177–187.2 indexed citations
9.
Niitani, H, Kiyoyuki Furuse, M. Fukuoka, Kazuya Hasegawa, & T Taguchi. (1994). [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].. PubMed. 21(2). 177–87.2 indexed citations
10.
K, Ota, A Wakui, H Majima, et al.. (1992). [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].. PubMed. 19(6). 855–61.30 indexed citations
Tominaga, T., Yoshiaki Nomura, Koji Enomoto, et al.. (1986). [Phase II study of epirubicin on breast cancer: a cooperative group study].. PubMed. 13(6). 2187–92.1 indexed citations
16.
Taguchi, T. (1986). [A phase I study of recombinant human tumor necrosis factor (rHu-TNF: PT-050). The PT-050 Study Group].. PubMed. 13(12). 3491–7.7 indexed citations
17.
Taguchi, T, et al.. (1986). [A prospective randomized trial comparing epirubicin and doxorubicin in advanced or recurrent breast cancer].. PubMed. 13(12). 3498–507.6 indexed citations
18.
Taguchi, T. (1985). [Arterial infusion method: its theory and clinical application--dosage and regimen].. PubMed. 12(4). 839–43.2 indexed citations
19.
Taguchi, T, Kenji Sakai, T. Terasawa, et al.. (1985). [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].. PubMed. 12(11). 2179–84.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.